26 Dec, 09:49 - Indian

SENSEX 78673.51 (0.26)

Nifty 50 23799.400390625 (0.30)

Nifty Bank 51502.8515625 (0.53)

Nifty IT 43598.8515625 (-0.16)

Nifty Midcap 100 56847.69921875 (-0.37)

Nifty Next 50 68879.703125 (0.03)

Nifty Pharma 22502.099609375 (-0.25)

Nifty Smallcap 100 18665.849609375 (-0.36)

26 Dec, 09:49 - Global

NIKKEI 225 39510.07 (0.97)

HANG SENG 20098.29 (1.08)

S&P 6114.75 (0.08)

Login/Signup
LOGIN HERE
Cancel

DMCC Speciality Chemicals Ltd

You are Here : Home > Markets > CompanyInformation > Board Meeting
BSE Code : 506405 | NSE Symbol : DMCC | ISIN : INE505A01010 | Industry : Chemicals |


Board Meeting
Announcement Date Date Of Meeting Purpose Detail
16-Oct-2024 28-Oct-2024 Quarterly Results DMCC Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2024 inter alia to consider and approve and take on record the Unaudited (Standalone & Consolidated) Financial Results of the Company for the quarter and half year ended September 30 2024 along with the Limited Review Reports thereon issued by the Statutory Auditors of the Company. As per the attachment. (As Per BSE Announcement dated on 28.10.2024)
26-Jul-2024 13-Aug-2024 Quarterly Results DMCC Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2024 inter alia to consider and approve and take on record the Unaudited (Standalone & Consolidated) Financial Results of the Company for the Quarter ended June 30 2024 along with the Limited Review Reports thereon issued by the Statutory Auditors of the Company. Dear Sir/Madam, Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements), 2015 ('Listing Regulations'), we wish to inform that the Board of Directors of the Company at its meeting held today i.e. on Tuesday, August 13, 2024 inter - alia considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2024, along with the Limited Review Reports thereon issued by the Statutory Auditors of the Company. Please refer pdf attachment for detailed information on the outcome. The Meeting of the Board of Directors commenced at 12:33 p.m. (IST) and concluded at 2:45 p.m. (IST) (As per BSE Announcement Dated on 13/08/2024)
16-May-2024 23-May-2024 Final Dividend DMCC Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2024 inter alia to consider and approve and take on record the Audited (Standalone & Consolidated) Financial Results of the Company for the Quarter and Year ended March 31 2024 and Recommendation of Final Dividend if any for the year ended March 31 2024. The Board at its meeting held on 23 May 2024 recommended a final dividend of Rs. 1/- per equity share of Rs. 10/- each for the financial year ended 31.03.2024 subject to approval of the shareholders at the ensuing Annual General Meeting Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements), 2015 ('Listing Regulations'), we wish to inform that the Board of Directors of the Company at its meeting held today i.e. on Thursday, May 23, 2024 inter - alia considered and approved the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2024, along with the Unmodified Audit Report thereon issued by the Statutory Auditors of the Company on the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2024. Please refer pdf attachment for detailed information on the outcome. The Meeting of the Board of Directors commenced at 02.15 PM (IST) and concluded at 05.15 p.m. (IST). The aforesaid results are also being made available on the Company''s website at www.dmcc.com You are requested to kindly take the same on your record. Please find enclosed herewith Disclosure under Regulation 30 of the Listing Regulations regarding appointment of Directors. Please find enclosed herewith the Disclosure under Regulation 30 Regarding the Appointment of Independent Director, Executive Director, Senior Management Personnel, Re-appointment of Secretarial Auditor and Re-appointment of Cost Auditor of the Company. (As Per BSE Announcement dated on 23.05.2024)
31-Jan-2024 09-Feb-2024 Quarterly Results DMCC Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 inter alia to consider and approve the Unaudited Standalone & Consolidated Financial Results of the Company for the Quarter and Nine Months ended 31st December 2023. Dear Sir/Madam, Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements), 2015 ('Listing Regulations'), we wish to inform that the Board of Directors of the Company at its meeting held today i.e. on February 09, 2024 inter - alia considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2023, along with the Unmodified Limited Review Report thereon issued by the Statutory Auditors of the Company. The Meeting of the Board of Directors commenced at 12.00 Noon (IST) and concluded at 01.20 p.m. (IST). Please find attached herewith Unaudited Standcalone and Consolidated Financial Results for the quarter and nine months ended 31.12.2023 (As Per BSE Announcement dated on 09.02.2024)
01-Nov-2023 08-Nov-2023 Quarterly Results DMCC Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/11/2023 inter alia to consider and approve the Unaudited (Standalone & Consolidated) Financial Results of the Company for the Quarter and Half year ended September 30 2023. Dear Sir/Madam, Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements), 2015 ('Listing Regulations'), we wish to inform that the Board of Directors of the Company at its meeting held today i.e. on November 08, 2023 inter - alia considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2023, along with the Unmodified Limited Review Report thereon issued by the Statutory Auditors of the Company. The Meeting of the Board of Directors commenced at 12.40 p.m. (IST) and concluded at 02.05 p.m.(IST). The aforesaid results are also being made available on the Company''s website at www.dmcc.com (As Per BSE Announcement dated on 08.11.2023)
02-Aug-2023 09-Aug-2023 Quarterly Results DMCC Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2023 inter alia to consider and approve and take on record the Unaudited (Standalone & Consolidated) Financial Results of the Company for the Quarter ended June 30 2023 A.G.M. & Quarterly Results (As per bse bulletin dated on 02.08.2023) Please find enclosed herewith Unaudited Standalone and Consolidated Financial Results for the quarter ended 30.06.2023 and Board Meeting outcome. Dear Sir/Madam, Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements), 2015 ('Listing Regulations'), we wish to inform that the Board of Directors of the Company at its meeting held today i.e. on August 09, 2023 inter -alia: 1. Considered and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2023, along with the Limited Review Reports thereon issued by the Statutory Auditors of the Company; 2. Decided to hold, the 102nd Annual General Meeting (AGM) of the Company on Tuesday, September 12, 2023 and the shareholders are hereby informed that the said AGM will be held through Video Conferencing (VC) /Other Audio Visual Means (OAVM). The Meeting of the Board of Directors commenced at 12.30 p.m. (IST) and concluded at 02.25 p.m. (IST). (As Per BSE Announcement Dated on 09.08.2023)
10-May-2023 17-May-2023 Accounts DMCC Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/05/2023 inter alia to consider and approve and take on record the Audited (Standalone & Consolidated) Financial Results of the Company for the Quarter and Year ended March 31 2023. Further pursuant to our letter dated March 30 2023 and in terms of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 and the Companys internal code of conduct for prevention of Insider Trading the Trading window for dealing in securities of the Company will remain closed till 48 hours post the outcome of board meeting i.e. till May 19 2023 the Trading window shall re-open on May 20 2023. Dear Sir/Madam, We would like to inform that the Board of Directors at its meeting held on May 17, 2023 inter-alia approved the appointment of Shri Sunil Kumar Goyal, as Chief Finance Officer and Key Managerial Personnel of the Company in terms of Section 203 of the Companies Act 2013 - w.e.f. May 18, 2023. The brief details of Shri Chief Finance Officer have been enclosed as an Annexure - I. Dear Sir/Madam, We would like to inform that the Board of Directors at its meeting held on May 17, 2023 inter-alia approved the following: 1. Appointment of Shri Sunil Kumar Goyal, as Chief Finance Officer and Key Managerial Personnel of the Company in terms of Section 203 of the Companies Act 2013 - w.e.f. May 18, 2023. The brief details of Shri Chief Finance Officer have been enclosed as an Annexure - I. 2. Re-appointment of Shri Satish Kumar Jain, Proprietor of SKJ & Associates, Practicing Company Secretaries (FCS 6398/ PCS 6632) as Secretarial Auditors of the Company to conduct the Secretarial Audit of the Company for the financial year ended March 31, 2024. The brief details have been enclosed as an Annexure - II. 3. Re-appointment Shri S. S. Dongare, Cost Accountant (Membership No. 012521) as the Cost Auditor of the Company to conduct the audit of Company's cost records for the financial year ended March 31, 2024. The brief details have been enclosed as an Annexure - II. (As Per BSE Announcement Dated on 18.05.2023)
31-Jan-2023 10-Feb-2023 Quarterly Results DMCC Speciality Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2023 inter alia to consider and approve Dear Sir/Madam Pursuant to the provisions of Regulation 29 and other applicable regulations if any of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Friday 10th February 2023 inter-alia to consider approve and take on record the Unaudited (Standalone & Consolidated) Financial Results of the Company for the quarter and nine months ended 31st December 2022. Further pursuant to our letter dated September 28 2022 and in terms of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 and the Companys internal code of conduct for prevention of Insider Trading the Trading window for dealing in securities of the Company will remain closed till 48 hours post the outcome of board meeting i.e. till February 12 2023 and the Trading window shall re-open on February 13 2023. Dear Sir/Madam, We wish to inform you that the Board at its meeting held today i.e. 10th February, 2023, has inter alia: 1. Considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2022, along with the Limited Review Reports thereon issued by the Statutory Auditors of the Company and Pursuant to Regulations 30 and 33 of SEBI (LODR), 2015 ('Listing Regulations'),the same are enclosed herewith. 2. Re-appointed Shri. Bimal Lalitsingh Goculdas (DIN : 00422783) as the Managing Director and Chief Executive Officer of the Company for the period of three consecutive years w.e.f. 1st April, 2023 to 31st March, 2026 . The aforesaid results are also being made available on the Company''s website at www.dmcc.com The Board Meeting commenced at 11.30 a.m. (IST) and concluded at 01.40 p.m. (IST). You are requested to kindly take the same on your record Dear Sir/Madam, We wish to inform you that the Board at its meeting held today i.e. 10th February, 2023, has inter alia: 1. Considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2022, along with the Limited Review Reports thereon issued by the Statutory Auditors of the Company and Pursuant to Regulations 30 and 33 of SEBI (LODR), 2015 ('Listing Regulations'),the same are enclosed herewith. 2. Re-appointed Shri. Bimal Lalitsingh Goculdas (DIN : 00422783) as the Managing Director and Chief Executive Officer of the Company for the period of three consecutive years w.e.f. 1st April, 2023 to 31st March, 2026 . The aforesaid results are also being made available on the Company''s website at www.dmcc.com Dear Sir/Madam, Pursuant to Regulation 30 of SEBI read with Schedule III of the (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), we would like to inform you that Mr. Chirag Jawant Shah has resigned from the office of Chief Finance Officer of the Company for the better prospects and he ceased to be Chief Finance Officer from the closing hours of today i.e. 10th February, 2023 and the same has been taken on record by the Board of Directors in their meeting held today i.e. 10th February, 2023. The Board placed on record their appreciation for the services rendered by him during his tenure as Chief Finance Officer (CFO) of the Company. The Company is in the process of identifying a suitable person for the said position. The disclosures as required under SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 09, 2015, are separately enclosed as Annexure - I. You are requested to kindly take the same on your record. Dear Sir/Madam, The Board of Directors of the Company, in its meeting, held today i.e. February 10, 2023, has inter-alia passed the Resolutions approving the following, after due consideration of the approval and recommendations of the Nomination and Remuneration Committee: Re-appointed Shri Bimal Lalitsingh Goculdas (DIN : 00422783) as the Managing Director and Chief Executive Officer of the Company for the period of three consecutive years w.e.f. 1st April, 2023 to 31st March, 2026. The above re-appointment is subject to the approval of the shareholders of the Company, vide Postal Ballot Process. Further, the details as required under regulation 30 of Listing Regulations read with SEBI Circular Ref. CIR/CFD/CMD/4/2015 dated 9th September, 2015 is enclosed herewith (Annexure I). You are requested to kindly take the same on your record. (As per BSE Announcement Dated on 10/02/2023)
31-Oct-2022 07-Nov-2022 Quarterly Results DHARAMSI MORARJI CHEMICAL CO.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/11/2022 inter alia to consider and approve and take on record the Unaudited (Standalone & Consolidated) Financial Results of the Company for the quarter and half year ended September 30 2022. Dear Sir/Madam, Pursuant to Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements), 2015 ('Listing Regulations'), the Board of Directors of the Company at its meeting held today i.e. 7th November, 2022, has inter-alia considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2022, along with the Limited Review Reports thereon issued by the Statutory Auditors of the Company. This aforesaid results are also being made available on the Company''s website at www.dmcc.com The Board Meeting commenced at 12.50 p.m. (IST) and concluded at 02.55 p.m. (IST). You are requested to kindly take the same on your record. (As Per BSE Announcement Dated on 07.11.2022)
05-Aug-2022 12-Aug-2022 Quarterly Results DHARAMSI MORARJI CHEMICAL CO.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2022 inter alia to consider and approve and take on record the Unaudited (Standalone & Consolidated) Financial Results of the Company for the quarter and half year ended June 30 2022. Further pursuant to our letter dated June 29 2022 and in terms of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 and the Companys internal code of conduct for prevention of Insider Trading the Trading window for dealing in securities of the Company will remain closed till 48 hours post the outcome of board meeting i.e. till August 14 2022 and the Trading window shall re-open on August 15 2022. As required under SEBI (LODR) Regulation 2015 this may be treated as an advance intimation. You are requested to kindly take the same on your record. Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements), 2015 ('Listing Regulations'), the Board of Directors of the Company at its meeting held today i.e. 12th August, 2022, has inter-alia considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2022 along with the Limited Review Reports thereon issued by the Statutory Auditors of the Company; Kindly refer the detailed outcome attached. The Board Meeting commenced at 12.00 Noon (IST) and concluded at 03.30 p.m. (IST). You are requested to kindly take the same on your record. (As per BSE Announcement Dated on 12/08/2022)
16-May-2022 24-May-2022 Accounts DHARAMSI MORARJI CHEMICAL CO.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2022 inter alia to consider and approve and take on record the Audited (Standalone & Consolidated) Financial Results of the Company for the quarter and year ended March 31 2022. We also wish to inform you that the Board inter-alia may consider the proposal of dividend on equity shares if any for the financial year 2021-22. Further pursuant to our letter dated March 31 2022 and in terms of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 and the Companys internal code of conduct for prevention of Insider Trading the Trading window for dealing in securities of the Company will remain closed till 48 hours post the outcome of board meeting i.e. till May 26 2022 the Trading window shall re-open on May 27 2022. As required under SEBI (LODR) Regulation 2015 this may be treated as an advance intimation. You are requested to kindly take the same on your record. Dharamsi Morarji Chemical Company Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 24, 2022, inter alia, has recommended Final Dividend of 10% (Rs. 1/- per equity share of Rs. 10/- each) for the Financial Year ended March 31, 2022, subject to the approval of the members at the ensuing Annual General Meeting (AGM). The said dividend, if declared at the ensuing Annual General Meeting (AGM), will be paid to the shareholders within 30 days of AGM of the Company. Decided to hold 101st Annual General Meeting on September 14, 2022. We wish to inform that The Board of Directors of the Company at its meeting held today i.e. on May 24, 2022, considered and approved the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2022 and we are enclosing herewith the same alongwith Auditor's Report on the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2022 issued by M/s Rahul Gautam Divan & Associates, Statutory Auditors of the Company; Dear Sir/Madam, Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements), 2015 ('Listing Regulations'), we wish to inform that: The Board of Directors of the Company at its meeting held today i.e. on May 24, 2022, considered and approved the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2022 and the same are enclosed herewith along with Auditor's Report on the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2022 issued by M/s Rahul Gautam Divan & Associates, Statutory Auditors of the Company; Declaration of Audit Report with Unmodified Opinion Pursuant to Regulation 33(3)(d) of the Listing Regulations, we hereby declare that M/s Rahul Gautam Divan & Associates, Statutory Auditors of the Company, have issued Audit Reports with unmodified opinion on the above financial results. (As Per BSE Announcement Dated on 24.05.2022) Please find attached herewith Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015 in connection with the meeting of the Board of Directors of the Company held on May 24, 2022. (As Per BSE Announcement Dated on 25.05.2022)
04-Feb-2022 11-Feb-2022 Quarterly Results DHARAMSI MORARJI CHEMICAL CO.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2022 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and Nine months ended 31st December 2021. Further in continuation of our intimation dated 28th December 2021 and in terms of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 and the Companys internal code of conduct for prevention of Insider Trading the Trading window for dealing in securities of the Company will remain closed till 48 hours post the outcome of board meeting i.e. till 13th February 2022 and the Trading window shall re-open on 14th February 2022. As required under SEBI (LODR) Regulation 2015 this may be treated as an advance intimation. You are requested to kindly take the same on your record. Dear Sir/Madam, we wish to inform that The Board of Directors of the Company at its meeting held today i.e. on 11th February, 2022 inter - alia considered and approved the Unaudited (Standalone and Consolidated) Financial Results of the Company for the quarter and nine months ended 31st December, 2021 and the same is enclosed herewith along with Limited Review Report on the same issued by M/s Rahul Gautam Divan & Associates, Statutory Auditors of the Company; Further the Board of Directors has also considered redemption of 2.5%, 280000 Nos. of Non-Convertible Cumulative Preference Shares of Rs. 100/- each on or before 31st March, 2022 and the Stock Exchanges will be updated on the completion of the said redemption. The Board Meeting commenced at 12:00 Noon (IST) and concluded at 2.55 p.m. (IST). (As Per BSE Announcement dated on 11.02.2022)
01-Nov-2021 01-Nov-2021 Quarterly Results Dear Sir/Madam, The Board of Directors of the Company at its meeting held today i.e. on 1st November, 2021 considered and approved the Unaudited (Standalone and Consolidated) Financial Results of the Company for the quarter and half year ended 30th September, 2021 and the same are enclosed herewith with Limited Review Report on the Unaudited (Standalone and Consolidated) Financial Results of the Company for the quarter and half year ended 30th September, 2021 issued by M/s Rahul Gautam Divan & Associates, Statutory Auditors of the Company. The said results are also being made available on the Company''s website at www.dmcc.com The Board Meeting commenced at 12:00 Noon (IST) and concluded at 2.25 p.m. (1ST). You are requested to kindly take the same on your record. We wish to inform that the Board of Directors of the Company at its meeting held today i.e. on 1st November, 2021 considered and approved the Unaudited (Standalone and Consolidated) Financial Results of the Company for the quarter and half year ended 30th September, 2021 the same are enclosed herewith along with Limited Review Report on the Unaudited (Standalone and Consolidated) Financial Results of the Company for the quarter and half year ended 30th September, 2021 issued by M/s Rahul Gautam Divan & Associates, Statutory Auditors of the Company; The said results are also being made available on the Company''s website at www.dmcc.com The Board Meeting commenced at 12:00 Noon (IST) and concluded at 2.25 p.m. (1ST). You are requested to kindly take the same on your record. (As per BSE Announcement Dated on 01/11/2021)
25-Sep-2021 23-Sep-2021 Others Dear Sir/Madam, In terms of provisions of Regulation 8(2) of (Prohibition of Insider Trading) Regulations, 2015, we are enclosing herewith Updated Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and their Immediate Relatives as approved by the Board at their meeting held on 23rd September, 2021. The same will also be updated on the website of the Company at www.dmcc.com You are requested to kindly take the same on your record.
30-Jul-2021 10-Aug-2021 Quarterly Results DHARAMSI MORARJI CHEMICAL CO.LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2021 ,inter alia, to consider and approve and take on record the Unaudited (Standalone & Consolidated) Financial Results of the Company for the quarter ended 30th June, 2021. Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements), 2015 ('Listing Regulations'), we wish to inform that the Board of Directors of the Company at its meeting held today i.e. on 10th August, 2021 considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended 30th June, 2021 and the said results along with Limited Review Report issued by M/s Rahul Gautam Divan & Associates, Statutory Auditors of the Company; are also being made available on the Company''s website at www.dmcc.com The Annual General Meeting (AGM) of the Company is scheduled to be held on Wednesday, 22nd September, 2021 through Video Conferencing (VC) /Other Audio Visual Means(OAVM) The Board Meeting commenced at 12:00 Noon (1ST) and concluded at 2.15 p.m. (1ST). The Board of Directors of the Company at its meeting held today i.e. on 10th August, 2021 considered and approved the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended 30th June, 2021 and we are enclosing herewith: a) Unaudited Standalone & Consolidated Financial Results of the Company for the quarter ended 30th June, 2021; b) Limited Review Report on the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended 30th June, 2021 issued by M/s Rahul Gautam Divan & Associates, Statutory Auditors of the Company; The said results are also being made available on the Company''s website at www.dmcc.com The Annual General Meeting (AGM) of the Company is scheduled to be held on Wednesday, 22nd September, 2021 through Video Conferencing (VC) /Other Audio Visual Means(OAVM) The Board Meeting commenced at 12:00 Noon (1ST) and concluded at 2.15 p.m. (1ST). Dharamsi Morarji Chemical Company Ltd has informed BSE regarding Outcome of Board Meeting held on August 10, 2021. (As Per BSE Announcement dated on 10.08.2021)
1 2